Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Izzy who wrote (4802)	7/7/1998 11:03:00 PM
From: Oliver & Co	Read Replies (1) of 6136

Hi Izzy, I have been reading the posts of the past few days, and watched as AGPH dropped. Tonight I attended a conference given by Dr. Margaret Fischl (sponsored by Merck) about the Geneva conference. As I see it, there is nothing bad about Viracept, if anything there were a lot of good news about Viracept. It is good in combo with Sustiva, and Abacavir. She said they had presented data on combination of Norvir (400 mg BID) and Nelfinavir (500 mg BID), and guess, the AUC of Nelf was compararable with 750 mg tid by itself, and also that the active M (?) metabolite was increased, wow! I agree with you that this is a good time to buy more AGPH, for some reason, everytime there is a conference, or there are good news this stock takes a beating. I hope you are doing good. JLL

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next